Mean (SD) plasma concentration-time profiles (n = 34) of emtricitabine (A), rilpivirine (B) and tenofovir (C) over 192 hours after administration of Test Formulation 1 and Reference formulation. Measurable concentrations of emtricitabine and tenofovir (A and C, respectively) were observed up to 96 hours after administration of study treatments.
FTC = emtricitabine; RPV = rilpivirine; TFV = tenofovir
